Treatment patterns after first-line abemaciclib therapy in patients with HR+, HER2- metastatic breast cancer in Japan.

Ibrance (palbociclib) - Pfizer

Verzenio (abemaciclib) - Eli Lilly

fulvestrant - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42725709

Tomoko Terasawa; Tomoyuki Aruga; Toshimi Takano; Tsutomu Kawaguchi; Yoichi Naito; Yoshinori Tanizawa

Sep 12, 2026